Dedifferentiated Liposarcoma
Also known as: Liposarcoma, Dedifferentiated / Liposarcomas, Dedifferentiated / Dedifferentiated liposarcoma (disorder) / Dedifferentiated liposarcoma (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11945 | Avelumab | 1 | Active Not Recruiting | 1 |
| DB18104 | TP-1287 | 1 | Terminated | 1 |
| DB17520 | Vimseltinib | 1 | Active Not Recruiting | 1 |
| DB12001 | Abemaciclib | 2 | Active Not Recruiting | 1 |
| DB06772 | Cabazitaxel | 2 | Completed | 1 |
| DB17506 | Etrumadenant | 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB18299 | N-(4-(1-cyclopropyl-4-fluoro-2-methyl-1H-benzo(d)imidazol-6-yl)-5-fluoropyrimidin-2-yl)-6-(2-(dimethylamino)ethyl)-5,6,7,8-tetrahydro-l,6-naphthyridin-2-amine | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB15102 | Pemigatinib | 2 | Not Yet Recruiting | 1 |
| DB01132 | Pioglitazone | 2 | Recruiting | 1 |
| DB05626 | Retaspimycin | 2 | Withdrawn | 1 |
| DB15766 | Retifanlimab | 2 | Not Yet Recruiting | 1 |
| DB11730 | Ribociclib | 2 | Unknown Status | 1 |
| DB05109 | Trabectedin | 2 | Recruiting | 1 |
| DB17505 | Zimberelimab | 2 | Recruiting | 1 |
| DB18578 | Brigimadlin | 2 / 3 | Active Not Recruiting | 1 |
| DB00997 | Doxorubicin | 2 / 3 | Active Not Recruiting | 1 |
| DB11942 | Selinexor | 2 / 3 | Completed | 1 |
| DB18578 | Brigimadlin | 3 | Recruiting | 1 |
| DB15257 | Milademetan | 3 | Terminated | 1 |
| DB05109 | Trabectedin | 3 | Terminated | 1 |